The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial

Article ID	Journal	Published Year	Pages	File Type
5587442	Diabetes Research and Clinical Practice	2017	26 Pages	PDF

Abstract

Personalized insulin treatment of type 1 diabetes based on single-patient evidence may improve outcomes significantly compared to a general treatment approach.

Keywords

EMA HbA1c NPH FDA Insulin analogs European Medicines agency the Food and Drug Administration Human insulin Personalized therapy Type 1 diabetes Neutral protamine hagedorn Severe hypoglycemia Probe

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Endocrinology

Preview

The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial

Authors

Ulrik Pedersen-Bjergaard, Peter L. Kristensen, Henning Beck-Nielsen, Kirsten NÃ¸rgaard, Hans Perrild, Jens S. Christiansen, Tonny Jensen, Hans-Henrik Parving, Birger Thorsteinsson, Lise Tarnow,